Pandemics

Current reading Moderate Risk
History 426 daily observations
Method Curated sources and AI scoring

Pandemics Risk

3.7 / 5
Moderate Risk -0.3 from previous reading

Current assessment

Current infectious disease threats, including COVID-19, avian flu, and Ebola, present a moderate pandemic risk due to ongoing outbreaks and emerging pathogen variants.

Latest run

August 8, 2026

Download Pandemics risk data .xlsx Complete history · 426 daily observations · Scores · Analysis · Actions · Articles

Trend

Daily score history for Pandemics.

Risk Drivers

What is pushing the current reading.

The threat level is influenced by several concurrent factors: the persistence of COVID-19 and its long-term effects, such as long COVID, which affects a significant portion of healthcare workers, and the potential for severe COVID to reactivate dormant viruses. Additionally, there are ongoing outbreaks of avian flu, particularly H5N1, in various regions, including the US and China, which pose a risk of zoonotic transmission. The Ebola outbreak in the Democratic Republic of the Congo remains a significant concern, with cases continuing to rise despite vaccination efforts. Furthermore, misinformation and political challenges, such as the controversy surrounding public health figures like Fauci, complicate public health responses. Surveillance gaps, particularly in underreported populations, and the slow uptake of vaccines in certain areas exacerbate these risks.

Risk Reduction Actions

Priority actions generated from the current analysis.

Government

Enhance surveillance and reporting mechanisms for emerging infectious diseases to ensure timely detection and response.

Public Health Agencies

Increase public awareness campaigns to combat misinformation and promote vaccination, especially in vulnerable populations.

Healthcare Providers

Prioritize research and treatment for long COVID and other post-viral syndromes to mitigate long-term health impacts.

International Organizations

Coordinate global efforts to address zoonotic diseases and improve cross-border collaboration on outbreak containment.

Research Institutions

Accelerate the development and distribution of vaccines for emerging pathogens, leveraging new technologies like mRNA.

Sources Monitored

Visible feeds used in this category's nightly run.

Selected Articles

Supporting articles referenced in the latest score.